Ethanolic Extracts of Vitex Doniana Possesses Hepatocuractive Property in Poloxamer Induced Hyperlipidemia
Science Research
Volume 2, Issue 3, June 2014, Pages: 49-54
Received: Apr. 25, 2014; Accepted: May 28, 2014; Published: Jun. 20, 2014
Views 3439      Downloads 189
Authors
Victor Duniya Sheneni, Department of Biochemistry, Ahmadu Bello University, Samaru Zaria, Nigeria
Dorcas Bolanle James, Department of Biochemistry, Ahmadu Bello University, Samaru Zaria, Nigeria
Sunday Eneojo Atawodi, Department of Biochemistry, Ahmadu Bello University, Samaru Zaria, Nigeria
Article Tools
Follow on us
Abstract
The hypolipidemic effect of Vitex doniana ethanolic leaves, stem bark and root bark extracts on some biochemical parameters in Poloxamer 407 (P407) induced hyperlipidemic rats was studied for a period of 21 days. Fifty four mixed sex rats weighing 100-200g were divided into nine groups comprising six animals per group: group given feed and water only, group induced by an intra-peritoneal injection of P407 every 48 hours without treatment, groups induced and treated with atorvastatin, leaves, stem bark, root bark extracts and groups of normal rats treated with leaves, stem bark and root bark extracts without induction. In all the groups, P407, atorvastatin, leaves, stem bark and root bark extracts were administered at a dose of 1000mg/kg, 20mg/kg, 100mg/kg, 100mg/kg and 30mg/kg body weight respectively. Blood samples were collected from the rats in all the groups at the end of the 21 days of treatment for determination of serum levels of; aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), total protein (TP), total bilirubin (TB), indirect bilirubin (IB) and direct bilirubin (DB) using Randox kits. Serum concentration of liver marker enzymes (AST, ALT and ALP) was significantly (p<0.05) higher in hyperlipidemic control group when compared to normal control and all treated groups. However there was a significant (p<0.05) decrease and non-significant (p>0.05) change in the levels of these marker enzymes in hyperlipidemic groups treated with the extracts and normal treated groups when compared with the hyperlipidemic and normal control group respectively. There was a significantly (p<0.05) lower level of TP, DB and a significantly (p<0.05) higher level of TB, ID in hyperlipidemic group when compared with rats in the normal control and all treated groups. Normal groups treated with the extracts without induction shows a non-significant (p>0.05) difference in TP, DB, TB and ID when compared with normal control group. These results highlight the efficacy of Vitex doniana (leaves, stem bark and root bark) ethanolic extracts in the amelioration of some undesirable effects of hyperlipidemia.
Keywords
Vitex Doniana, Hyperlipidemia, Poloxamer 407, Biochemical Parameters
To cite this article
Victor Duniya Sheneni, Dorcas Bolanle James, Sunday Eneojo Atawodi, Ethanolic Extracts of Vitex Doniana Possesses Hepatocuractive Property in Poloxamer Induced Hyperlipidemia, Science Research. Vol. 2, No. 3, 2014, pp. 49-54. doi: 10.11648/j.sr.20140203.14
References
[1]
Azzam H.S, Goertz C, Fritts M, Jonas WB (2007). Natural products and chronic hepatitis C virus. Liver Int.; 27:17–25.
[2]
Luk J.M, Wang X, Liu P, Wong K.F, Chan K.L, Tong Y, et al. (2007). Traditional Chinese herbal medicines for treatment of liver fibrosis and cancer: From laboratory discovery to clinical evaluation. Liver Int.; 27:879–90.
[3]
Ball K.R, and Kowdley K.V (2005). A review of Silybummarianum (milk thistle) as a treatment for alcoholic liver disease. Journal of Clinical Gastroenterol.; 39:520–8.
[4]
Mayer K.E, Myers R.P, Lee S.S (. 2005). Silymarin treatment of viral hepatitis: A systematic review. Journal of Viral Hepatitis; 12:559–6.
[5]
Luper S, (1998). A review of plants used in the treatment of liver disease: Part 1. Alternative Medicine Review; 3:410–21.
[6]
Luper S, (1999). A review of plants used in the treatment of liver disease: Part 2. Alternative Medicine Review; 4:178–88.
[7]
W.H.O, (1998). Medicinal plants and the pharmaceutical industry. New Crops. Wiley, New York.
[8]
Quideau, S., Deffieux, D., Douat‐Casassus, C., and Pouysegu, L. (2011). Plant polyphenols: chemical properties, biological activities, and synthesis.AngewandteChemie International Edition, 50(3), 586-621.
[9]
Graf B.A, Milbury P.E, Blumberg J.B (2005). Flavonols, flavonones, flavanones and human health: Epidemological evidence. Journal of Medicinal Food. 8:281–290.
[10]
Arts I.C.W, Hollman P.C.H (2005). Polyphenols and disease risk in epidemiologic studies. America Journal of Clinical Nutrition; 81:317–325.
[11]
Assy N, Kaita K, Mymin D, Levy C, Rosser B, Minuk G (2000) Fatty infiltration of liver in hyperlipidemic condition. Digestive Dis Sci45 (10): 1929-1934.
[12]
Burkill H.M. (2000). Useful Plants of WestTropical Africa. 2nd ed. Vol. 5. Royal Botanic Garden Kew. PP 272-275.
[13]
James DB, Owolabi OA, Bisalla M, Jassium H (2010). Effects of aqueous extracts (leaves and stem) of Vitex doniana on carbon tetrachloride induced liver injury in rats. British Journal of Pharmacological Toxicology; 1(1): 1-5.
[14]
Lorke D (1983) A new approach to practical acute toxicity testing. Arch Toxicol54 (4): 275-287.
[15]
Johnston T.P, Palmer W.K (1993). Mechanism of poloxamer 407 induced hypertriglyceridemia in the rat. Journal of Biochemical Pharmacology 46: 1037-1042.
[16]
Johnston T.P and Palmer W.K (1997).Effect of Poloxamer 407 on the activity of microsomal 3-hydroxy-3 methylglutaryl CoA reductase in rats. Journal of Cardiovascular Pharmacology 29: 580-85.
[17]
Blonder JM, Baird L, Fulfs JC (1999). Dose-dependent hyperlipidemia in rabbits following administration of poloxamer 407 gel. Life Science 65: 261-66.
[18]
Johnston T.P and Miller S.C (1985). Tox-icological evaluation of poloxamers for intramuscular use. J Parent Sci Technol 39: 83-8.
[19]
Johnston T.P Nguyen L.B Chu W.A (2001). Potency of select statin drugs in a new mouse model of hyperlipidemia and atheros-clerosis. Internation Journal of Pharmacology 229: 75-86.
[20]
HyeungSikLeea, Hyo Chan Ahna, Sae KwangKub (2006). Hypolipemic effect of water extracts of Picrorrhizarhizoma in PX-407 induced hyperlipemic ICR mouse model with hepatoprotective effects: A prevention study. Journal of Ethnopharmacology Volume 105, Pages 380–386.
[21]
Ameh D.A, Adejo E.B, James D.B, (2013). Effect of Garcinal Kola biflavonoid fractions on some biochemical parameters of P407-induced hyperlipidemia rats: A phytopreventive and phytotheraupeutic studies.
[22]
Johnston TP, Baker JC, Jamal AS, Hall DD, Emeson EE, Palmer WK (1999) Potential down regulation of HMG-CoA reductase after prolonged administration of P-407 in C57BL/6 mice. Journal of Cardi-ovascular Pharmacology 34: 831–842.
[23]
Lu LS, Wu CC, Hung LM, Chiang MT, Lin CT, Lin CW, Su MJ (2007) Apocynin alleviated hepatic oxidative burden and reduced liver injury in hypercholesterolaemia. Liver Int27: 529-537. Damage in Rats. ScientiaPharmaceutica, 76: 203–215.
[24]
Day, C.P, James, O.F. (1998). Steatohepatitis: a tale of two “hits” Gastroenterology, 114(4), 842-845.
[25]
MuthuGounderPalanivel, BalasubramanianRajkapoor, RajuSenthil Kumar, John Wilking Einstein, EkambaramPrem Kumar, Mani Rupesh Kumar, KunchuKavitha, MohanrajPradeep Kumar and BalasundaramJayakar, (2008). .Hepatoprotective and Antioxidant Effects of PisoniaAculeataL. Against CCl4- Induced Hepatic.
[26]
ChavanSandeep D., PatilSandeep B, NaikwadeNilofar S. (2012) Biochemical And Histopathological Studies of ButeaMonosperma(Lam) Taub Leaves On Paracetamol Induced Hepatotoxicity In Albino Rats. Journal of Pharmacy Research, 5(8):4006-4008.
[27]
Uthandi A, Ramasamy K (2011). Hepatoprotective activity of Sesame meal on high fat fed Wistar rats. International Journal of Pharmaceutical Sciences Research, 2(12): 205-211.
[28]
Saad B, Azaizeh H, Abu-Hijleh G, Said S (2006) Safety of traditional Arab herbal medicine. Evidence Based Alternative Medicine, 3: 433-439.
[29]
Usha, M. G., Duan, S. Z., and Mortensen, R. M. (2008). Liver function parameters. Current opinion in hepathology 18(2), 128-133.
ADDRESS
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
U.S.A.
Tel: (001)347-983-5186